Loading…
AIM ImmunoTech Inc. is projected to decline to $0.3938 by 2027, a -2% move from its current price of $0.4011. AIM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.3554 | $0.4008 | $0.4521 | -0.06% |
| May 30 | $0.3379 | $0.4006 | $0.4749 | -0.13% |
| May 31 | $0.325 | $0.4003 | $0.4932 | -0.19% |
| Jun 1 | $0.3145 | $0.4001 | $0.509 | -0.25% |
| Jun 2 | $0.3055 | $0.3998 | $0.5233 | -0.32% |
| Jun 3 | $0.2975 | $0.3996 | $0.5366 | -0.38% |
| Jun 4 | $0.2904 | $0.3993 | $0.5491 | -0.45% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2904 | $0.3993 | $0.5491 | -0.45% |
| Week 2 | $0.2534 | $0.3975 | $0.6238 | -0.89% |
| Week 3 | $0.2279 | $0.3958 | $0.6871 | -1.33% |
| Week 4 | $0.2084 | $0.394 | $0.745 | -1.77% |
| Week 5 | $0.1924 | $0.3923 | $0.7996 | -2.21% |
| Week 6 | $0.179 | $0.3905 | $0.8521 | -2.64% |
| Week 7 | $0.1674 | $0.3888 | $0.903 | -3.08% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
AIM ImmunoTech Inc. is a healthcare company focused on immuno-pharma research and development. It conducts therapeutics development aimed at cancers, viral diseases, and immune-deficiency disorders in the United States.
Its flagship products are Ampligen (rintatolimod), a drug consisting of large macromolecular double-stranded RNA molecules to treat chronic fatigue syndrome, and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts.
The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was founded in 1966 and is headquartered in Ocala, Florida.
AIM ImmunoTech Inc. is listed with a current price of $0.4011 per share and a market capitalization of $5.84M. It is ranked 5234 by market capitalization among listed securities. The stock shows a near-term neutral to flat path in its forecast, with year-by-year estimates extending into 2050 that project gradual upside in price and substantial long-run ROI potential.
In the near term, the 2026 average price is $0.4011 with a 2026 low of $0.23 and a 2026 high of $0.5693, corresponding to a neutral stance. From 2028 onward, the forecasts turn more bullish, culminating in a 2050 average of $1.27 and a 2050 max of $2.92, with a long-run bullish sentiment and notable upside potential.
A major floor 83.4% below — a decisive break under it would weaken the trend.
The nearest floor, 42.7% below — buyers have tended to step in here.
The nearest ceiling, 39.6% above — a clean break opens room to run.
A major ceiling 224.0% above — clearing it would confirm fresh momentum.
Key AIM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AIM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.272 | Buy | $0.3072 | Buy |
| MA 10 | $0.296 | Buy | $0.3162 | Buy |
| MA 20 | $0.377 | Buy | $0.366 | Buy |
| MA 50 | $0.534 | Sell | $0.5242 | Sell |
| MA 100 | $0.7862 | Sell | $0.9051 | Sell |
| MA 200 | $1.42 | Sell | $2.76 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.80 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 14.07 | Neutral |
| Williams %R (14) | -48.48 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 17.65 | Buy |
| Bollinger %B (20,2) | 0.55 | Neutral |
| Stochastic %K (14) | 51.52 | Neutral |
| TRIX (15) | -2.22 | Sell |
| Awesome (5,34) | -0.17 | Sell |
| Ultimate (7,14,28) | 56.06 | Neutral |
| Momentum (10) | 0.11 | Buy |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 0.26 | Buy |
| ADX (14) | 26.76 | Sell |
| ATR (14) | 0.05 | Info |
The 30-day technical picture shows neutral sentiment overall. The RSI(14) is 50, indicating neutral momentum, while the 50-day simple moving average sits at $0.534 and the 200-day moving average at $1.42, highlighting near-term price pressures.
Support is placed at $0.23 and resistance at $0.56, framing a cautious trading range for the near term. The 30-day price range spans from $0.1814 to $0.887, illustrating the potential for substantial short-term movement within a relatively wide band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.23 | $0.4011 | $0.5693 | 0% | Neutral | |
| $0.2834 | $0.3938 | $0.5922 | -2% | Neutral | |
| $0.4168 | $0.6146 | $0.9825 | +53% | Bullish | |
| $0.4072 | $0.6321 | $1.06 | +58% | Bullish | |
| $0.3416 | $0.5557 | $0.9688 | +39% | Bullish | |
| $0.3102 | $0.5272 | $0.9509 | +31% | Bullish | |
| $0.2681 | $0.4752 | $0.8834 | +18% | Neutral | |
| $0.2967 | $0.5476 | $1.05 | +37% | Bullish | |
| $0.3619 | $0.6947 | $1.36 | +73% | Bullish | |
| $0.3757 | $0.7496 | $1.50 | +87% | Bullish | |
| $0.3856 | $0.8568 | $1.88 | +114% | Bullish | |
| $0.5709 | $1.27 | $2.92 | +216% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.23 | $0.4011 | $0.4721 | +0.00% |
| June 2026 | $0.3049 | $0.3657 | $0.4544 | -8.83% |
| July 2026 | $0.3103 | $0.3784 | $0.4823 | +3.49% |
| August 2026 | $0.3353 | $0.4144 | $0.5384 | +9.50% |
| September 2026 | $0.3227 | $0.4033 | $0.5323 | -2.67% |
| October 2026 | $0.3047 | $0.3848 | $0.5149 | -4.61% |
| November 2026 | $0.3201 | $0.4079 | $0.5525 | +6.01% |
| December 2026 | $0.3233 | $0.4156 | $0.5693 | +1.88% |
Click any year to see its month-by-month AIM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, AIM could reach as high as $0.5693, with a base case around $0.4011 and support toward $0.23 — roughly 0% from $0.4011. Price action looks broadly range-bound.
Expect AIM to range from $0.2834 to $0.5922 through 2027. The $0.3938 average target implies a -2% move from current prices. That is -2% versus the projected 2026 average. A consolidation phase looks the most probable path here.
The AIM price prediction for 2028 points to an average of $0.6146 (low $0.4168, high $0.9825) — a potential gain of +53% on today's $0.4011. Momentum favours further upside here.
In 2029, AIM is projected to trade between $0.4072 and $1.06, averaging $0.6321 — a potential gain of +58% from today's $0.4011. That is up +3% on the projected 2028 average. Buyers look set to stay in control over this stretch.
AIM ImmunoTech Inc.'s 2030 outlook centres on $0.5557, within a $0.3416 to $0.9688 range. That is -12% versus the projected 2029 average. That marks a +39% change versus current levels. Momentum favours further upside here.
By 2031, AIM could reach as high as $0.9509, with a base case around $0.5272 and support toward $0.3102 — roughly +31% from $0.4011. Buyers look set to stay in control over this stretch.
Expect AIM to range from $0.2681 to $0.8834 through 2032. The $0.4752 average target implies a +18% move from current prices. That is -10% versus the projected 2031 average. Price action looks broadly range-bound.
The AIM price prediction for 2033 points to an average of $0.5476 (low $0.2967, high $1.05) — a potential gain of +37% on today's $0.4011. Buyers look set to stay in control over this stretch.
In 2034, AIM is projected to trade between $0.3619 and $1.36, averaging $0.6947 — a potential gain of +73% from today's $0.4011. That is up +27% on the projected 2033 average. Momentum favours further upside here.
AIM ImmunoTech Inc.'s 2035 outlook centres on $0.7496, within a $0.3757 to $1.50 range. That is up +8% on the projected 2034 average. That marks a +87% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, AIM could reach as high as $1.88, with a base case around $0.8568 and support toward $0.3856 — roughly +114% from $0.4011. Momentum favours further upside here.
Expect AIM to range from $0.5709 to $2.92 through 2050. The $1.27 average target implies a +216% move from current prices. That is up +48% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in AIM today (≈ 2,493.143854 AIM) could be worth
$3,163.22
+$2,163.22 (+216%) by 2050 · US Dollar
Based on the average projected AIM price of $1.27 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AIMwould be worth at today's price.
$1,000 invested in AIM on May 27, 2025 (≈ 128.874995 AIM) would be worth
$51.69
-$948.31 (-94.8%) today · 0.05× · US Dollar
Based on a AIM entry price of $7.76 vs. today's $0.4011.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.25 | $1,604.4 | +60.4% |
| 1 month ago | $0.52 | $771.35 | -22.9% |
| 3 months ago | $0.99 | $405.15 | -59.5% |
| 6 months ago | $1.47 | $272.06 | -72.8% |
| 1 year ago | $7.76 | $51.69 | -94.8% |
| All time (5.0y) ago | $200.78 | $2 | -99.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AIM forecast.
Our base-case forecast reaches $0.80 around 2040.
Implied market cap at $0.80: $11.65M
Over the multi-year horizon, the price outlook shifts from neutral to bullish in several steps. The 2028 average price is $0.6146 with a 53.2% return, and 2029 averages at $0.6321 with a 57.6% return, signaling stronger upside momentum. By 2030, the average price is $0.5557 with a 38.5% ROI and a bullish sentiment; 2031 averages at $0.5272 (31.4% ROI).
The forecast strengthens further into 2034-2035, where the averages rise to $0.6947 and $0.7496 respectively, with ROIs of 73.2% and 86.9% and bullish sentiment. The path continues to 2040, with an average of $0.8568 and a 113.6% ROI, maintaining a bullish outlook. By 2050, the average price is projected at $1.27 with a max of $2.92 and a 216.3% ROI, underscoring a substantial long-run upside despite near-term volatility.
Nevertheless, the forecast also includes periods of neutral or softer momentum (e.g., 2027 with a -1.8% ROI and 2032 with an 18.5% ROI) and very high annualized volatility at 200%, reflecting notable risk around timing and magnitude of moves. These are estimates, not guarantees, and actual results can vary widely based on market conditions and company developments.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $0.5557 with a max of $0.9688 and a min of $0.3416, for an estimated ROI of 38.5% and a bullish sentiment.
Forecasts indicate a shift from neutral to bullish from 2028 through 2050, with increasing average prices and ROIs (e.g., 53.2% in 2028, 113.6% in 2040, and 216.3% in 2050). Near-term prospects include a neutral stance in 2026 and a -1.8% ROI in 2027, underscoring the presence of risk and volatility.
The 2050 maximum price in the forecast is $2.92, so reaching or exceeding $2 by 2050 is within the modeled upside.
The 30-day range is from $0.1814 to $0.887.
The current price is $0.4011 and the market cap is $5.84M.
AIM ImmunoTech Inc. Community Discussion
0Share your AIM ImmunoTech Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.